Patent details

Basic Information

Publication number:

EP1759701

PCT Application Number:

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP061208823

PCT Publication Number:

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

Buproprion Metabolites for treating dementia and other cerebrovascular disorders

French Title of Invention:

Métabolites du bupropion pour traiter la démence et d'autres maladies cérébrovasculaires

German Title of Invention:

Bupropinmetaboliten zur Behandlung von Dementia und anderen zerebrovasckulären Erkrankungen

SPC Number:

Dates

Filing date:

29/02/2000

Grant date:

22/12/2010

EP Publication Date:

22/12/2010

PCT Publication Date:

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

07/03/2007

EP B1 Publication Date:

22/12/2010

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

28/02/2011

Expiration date:

29/02/2020

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

29/02/2000

 

 

Name:

SEPRACOR INC.

Address:

84 Waterford Drive, Marlborough, MA 01752, United States (US)

Inventor

1

Name:

Jerussi Thomas, P.

Address:

United States (US)

2

Name:

Fang Qun, K.

Address:

United States (US)

3

Name:

McCullough John, R.

Address:

United States (US)

4

Name:

Senanayake Chrisantha, H.

Address:

United States (US)

Priority

1

Priority Number:

122277 P

Priority Date:

01/03/1999

Priority Country:

United States (US)

2

Priority Number:

148324 P

Priority Date:

11/08/1999

Priority Country:

United States (US)

3

Priority Number:

510241 P

Priority Date:

10/10/2003

Priority Country:

United States (US)

Classification

Main IPC Class:

A61K 31/5375;

Filing date	Document type	Number of pages